広範に中和する抗体とワクチン開発
Barton F Haynes1, Todd Bradley2
1Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina2Department of Medicine, Duke University School of Medicine, Durham, North Carolina3Department of Immunology, Duke University School of Medicine, Durham, North Carolin.
JAMA
|June 24, 2015
まとめ
No abstract available in PubMed .
さらに関連する動画
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
4.3K
04:47A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Published on: February 23, 2018
8.3K
関連する概念動画
Cross-reactivity
34.0K
Overview
34.0K
Humoral Immune Responses
86.9K
Overview
86.9K
Vaccines
51
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
51
Antibody Actions
3.9K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.9K
Vaccinations
54.1K
Overview
54.1K
Vaccine Production
72
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
72
